Alnylam Pharmaceuticals, Inc.
Cash Flow Statement
| Line Item | FY2009 | FY2008 |
|---|---|---|
| Operating Activities | ||
| Net Income | $-47.6M | $-26.2M |
| Depreciation & Amortization | $6.0M | $5.7M |
| Depreciation | — | — |
| Amortization | — | — |
| Stock-Based Compensation | $19.7M | $18.0M |
| Net Cash from Operating Activities | $-72.1M | $65.5M |
| Investing Activities | ||
| Capital Expenditures | $4.9M | $10.8M |
| Business Acquisitions | — | — |
| Net Cash from Investing Activities | $14.4M | $17.9M |
| Financing Activities | ||
| Dividends Paid | — | — |
| Stock Repurchases | — | — |
| Net Cash from Financing Activities | $3.5M | $3.2M |
| Net Change in Cash | $-54.3M | $86.6M |
| Free Cash Flow | $-77.1M | $54.7M |